Commonwealth Equity Services’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Buy
58,442
+2,785
+5% +$12.9K ﹤0.01% 3752
2025
Q4
$306K Sell
55,657
-2,600
-4% -$12.6K ﹤0.01% 3635
2025
Q3
$191K Sell
58,257
-1,779
-3% -$5.04K ﹤0.01% 3961
2025
Q2
$139K Sell
60,036
-33
-0.1% -$72 ﹤0.01% 4005
2025
Q1
$83K Buy
60,069
+1,000
+2% +$1.67K ﹤0.01% 4014
2024
Q4
$102K Buy
59,069
+31,000
+110% +$64.3K ﹤0.01% 3903
2024
Q3
$56K Buy
28,069
+800
+3% +$1.75K ﹤0.01% 3923
2024
Q2
$61K Hold
27,269
﹤0.01% 3875
2024
Q1
$78K Buy
27,269
+500
+2% +$1.04K ﹤0.01% 3841
2023
Q4
$47K Sell
26,769
-202
-0.7% -$403 ﹤0.01% 3764
2023
Q3
$85K Buy
26,971
+8,246
+44% +$15.4K ﹤0.01% 3592
2023
Q2
$12K Hold
18,725
﹤0.01% 3779
2023
Q1
$14 Buy
18,725
+5,000
+36% +$6.46K ﹤0.01% 3701
2022
Q4
$31K Buy
+13,725
New +$27.8K ﹤0.01% 3564

Other funds holding TSHA